Laboratory Co. of America (LH) Stock Forecast & Price Target

$229.15 +0.96 (+0.42%)

As of 01/3/2025 05:22 PM Eastern

Laboratory Co. of America - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 16 Analyst Ratings

Sell
0

Hold
4

Buy
12

Based on 16 Wall Street analysts who have issued ratings for Laboratory Co. of America in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 4 have given a hold rating, 11 have given a buy rating, and 1 has given a strong buy rating for LH.

Consensus Price Target

$258.62
12.86% Upside

According to the 16 analysts' twelve-month price targets for Laboratory Co. of America, the average price target is $258.62. The highest price target for LH is $289.00, while the lowest price target for LH is $230.00. The average price target represents a forecasted upside of 12.86% from the current price of $229.15.

Get the Latest News and Ratings for LH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Laboratory Co. of America and its competitors.

LH Analyst Ratings Over Time

Type	Current Forecast 1/6/24 to 1/5/25	1 Month Ago 12/7/23 to 12/6/24	3 Months Ago 10/8/23 to 10/7/24	1 Year Ago 1/6/23 to 1/6/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	10 Buy rating(s)	10 Buy rating(s)	8 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$258.62	$255.92	$253.00	$242.00
Forecasted Upside	12.86% Upside	10.09% Upside	19.32% Upside	7.36% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

LH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

LH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Laboratory Co. of America Stock vs. The Competition

Type	Laboratory Co. of America	Medical Companies	S&P 500
Consensus Rating Score	2.81	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	12.86% Upside	23,606.48% Upside	14.53% Upside
News Sentiment Rating	Positive News See Recent LH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$260.00 ➝ $270.00	+17.38%
12/13/2024	Bank of America 3 of 5 stars		Boost Target	Buy ➝ Buy	$262.00 ➝ $271.00	+16.67%
12/10/2024	Jefferies Financial Group 2 of 5 stars		Reiterated Rating	Buy	$265.00 ➝ $275.00	+16.45%
10/30/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Herholdt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
10/30/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
10/28/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Westenberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$235.00 ➝ $240.00	+6.14%
Get the Latest News and Ratings for LH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.
10/25/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$234.00 ➝ $249.00	+8.69%
10/25/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$282.00 ➝ $289.00	+25.61%
9/24/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	In-Line ➝ In-Line	$250.00 ➝ $240.00	+8.83%
8/2/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$260.00 ➝ $270.00	+14.63%
8/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$220.00 ➝ $230.00	-2.35%
8/2/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$255.00 ➝ $275.00	+18.79%
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$261.00 ➝ $243.00	+25.49%
3/25/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$250.00	+17.23%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$260.00	+18.63%
10/31/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$257.00 ➝ $230.00	+16.07%
8/14/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$290.00 ➝ $270.00	+23.85%
8/2/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$247.41 ➝ $231.00	+8.14%
4/26/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$260.00 ➝ $235.00	+6.14%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:23 AM ET.

Should I Buy Laboratory Co. of America Stock? LH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 27, 2024. Please send any questions or comments about these Laboratory Co. of America pros and cons to contact@marketbeat.com.

Laboratory Co. of America
Bull Case

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

The company recently reported earnings of $3.50 per share, exceeding analysts' expectations, which indicates strong financial performance and effective management.
Laboratory Co. of America Holdings has shown a year-over-year revenue increase of 7.4%, suggesting growth potential and resilience in its business model.
With a current stock price of approximately $229.53, the stock is trading near its 50-day moving average, indicating stability in its recent performance.
Institutional investors hold 95.94% of the company's stock, reflecting strong confidence from major financial players in the market.
The company has a solid return on equity of 15.27%, which demonstrates its ability to generate profit from shareholders' equity, a positive sign for potential investors.

Laboratory Co. of America
Bear Case

Investors should be bearish about investing in Laboratory Co. of America Holdings for these reasons:

The stock has experienced a decline of 2.1% recently, which may indicate volatility and potential challenges in maintaining its market position.
With a price-to-earnings (P/E) ratio of 44.56, the stock may be considered overvalued compared to its earnings, suggesting that investors could be paying a premium for the stock.
The company has a net margin of only 3.43%, which may raise concerns about profitability and cost management in a competitive market.
Despite recent growth, the company faces ongoing challenges in the medical research sector, which could impact future performance and investor confidence.
The stock's beta of 1.05 indicates that it is slightly more volatile than the market, which could lead to higher risk for investors during market fluctuations.

LH Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Laboratory Co. of America is $258.62, with a high forecast of $289.00 and a low forecast of $230.00.
: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last year. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" LH shares.
: According to analysts, Laboratory Co. of America's stock has a predicted upside of 12.86% based on their 12-month stock forecasts.
: Over the previous 90 days, Laboratory Co. of America's stock had 2 upgrades by analysts.
: Laboratory Co. of America has been rated by research analysts at Bank of America, Barclays, Hsbc Global Res, HSBC, Jefferies Financial Group, Morgan Stanley, Piper Sandler, and Robert W. Baird in the past 90 days.
: Analysts like Laboratory Co. of America less than other "medical" companies. The consensus rating score for Laboratory Co. of America is 2.81 while the average consensus rating score for "medical" companies is 2.82. Learn more on how LH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:LH) was last updated on 1/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Laboratory Co. of America (LH) Stock Forecast & Price Target